research article link, page-2

Fantastic find vapor!!

My molecular biology and protein chemistry are not up to much so I can't follow too much of the minutiae but there's enough there to realise one important thing.

It's this: no matter what the outcome of clinical trialling with BIT225, it's clear that Biotron appear to have cornered a very significant part of an Achilles heal of the Hc virus, the p7 protein and that the science of this is becoming understood. The big question, and one we have to hope the answer is to our favour, is the strength of the Biotron patents. Have they covered the area such that Biotron really does hold a unique key that means that only they can access this weakness of the virus without others being able to either work around the issue or find a loophole in the patents which allow them to exploit this technology.

In the end, it may be the intellectual property that is worth more than BIT225.